Impact of contralateral carotid or vertebral artery occlusion in patients undergoing carotid endarterectomy or carotid artery stenting Shin-Seok Yang, MD, Young-Wook Kim, MD, PhD, Dong-Ik Kim, MD, PhD, Keon-ha Kim, MD, PhD, Pyoung Jeon, MD, PhD, Gyeong- Moon Kim, MD, PhD, Chin-Sang Chung, MD, PhD, Kwang-Ho Lee, MD, PhD Journal of Vascular Surgery Volume 59, Issue 3, Pages 749-755 (March 2014) DOI: 10.1016/j.jvs.2013.10.055 Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 1 Frequencies of early symptomatic neurologic complications (ESNCs) according to treatment type and presence of the contralateral carotid occlusion (CCO) and/or vertebral artery occlusion (VAO). CAS, Carotid artery stenting; CEA, carotid endarterectomy; Group I, patients without CCO or VAO; Group II, patients with CCO with or without one or both VAOs; Group III, patients with one or both VAOs and without CCO; NS, not significant. Journal of Vascular Surgery 2014 59, 749-755DOI: (10.1016/j.jvs.2013.10.055) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 2 Frequencies of early postprocedural stroke rates according to treatment type and presence or absence of contralateral carotid occlusion (CCO) and/or vertebral artery occlusion (VAO). CAS, Carotid artery stenting; CEA, carotid endarterectomy; Group I, patients without CCO or VAO; Group II, patients with CCO with or without one or both VAOs; Group III, patients with one or both VAOs and without CCO; NS, not significant. Journal of Vascular Surgery 2014 59, 749-755DOI: (10.1016/j.jvs.2013.10.055) Copyright © 2014 Society for Vascular Surgery Terms and Conditions